HeXun Biosciences Co., Ltd. (6986.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan · ISIN TW0006986003
Price
43.40 TWD
Market cap
2.26 bn TWD
P/E (2025)
17.84
P/S (2025)
7.72
Dividend yield
0.45 %
Net margin
38.16 %
Return on equity (ROE)
15.09 %
Return on assets (ROA)
13.37 %
HeXun Biosciences Co., Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 286.42 m TWD | 293.23 m TWD |
| Gross profit | 260.67 m TWD | 266.28 m TWD |
| Operating income | 155.73 m TWD | 118.01 m TWD |
| EBIT | 162.64 m TWD | 127.04 m TWD |
| Net income | 147.22 m TWD | 111.91 m TWD |
| Diluted EPS – continuing operations | 3.20 TWD | 2.43 TWD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About HeXun Biosciences Co., Ltd.
HeXun Biosciences Co., Ltd. engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan. It provides contract manufacturing; commissioned inspection; aseptic filling; and consulting services. The company was founded in 2019 and is based in Taoyuan City, Taiwan.
More stocks
- Withuspharmaceutical Co.Ltd (330350.KQ)
- Chumporn Palm Oil Industry Public Company Limited (CPI.BK)
- CANEX Metals Inc (CANX.V)
- Onano Industrial Corp (6405.TW)
- Genasys Inc. (GNSS)
- Sambo Motors Co. Ltd (053700.KQ)
- Morefield Group N.V. (MORE.AS)
- JUPITER NEUROSCIENCES, INC. (JUNS)
- Strong H Machinery Technology (Cayman) Incorporation (4560.TW)
- Gseven Co Ltd (2937.TWO)
- T&R Biofab Co. Ltd (246710.KQ)
- CHAMPIONS ONCOLOGY, INC. (CSBR)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.